857 results on '"Haie-Meder, Christine"'
Search Results
2. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factors
Catalog
Books, media, physical & digital resources
3. Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis
4. Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis
5. Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis
6. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
7. Results of image guided brachytherapy for stage IB cervical cancer in the RetroEMBRACE study
8. Education and training for image-guided adaptive brachytherapy for cervix cancer—The (GEC)-ESTRO/EMBRACE perspective
9. Esophageal brachytherapy: Institut Gustave Roussy's experience
10. Hypnosedation for endocavitary uterovaginal applications: A pilot study
11. Recommendations from gynaecological (GYN) GEC-ESTRO working group – ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancer
12. Radiobiology: Foundation and New Insights in Modeling Brachytherapy Effects
13. Impact of suboptimal tandem implantation on local control and complications in intracavitary brachytherapy for cervix cancer
14. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
15. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer
16. Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort
17. SO006/#55 Regular dilation and/or sexual activity show less risk for vaginal stenosis in cervical cancer patients
18. Testicular transposition in children undergoing brachytherapy for bladder and/or prostate rhabdomyosarcoma
19. Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study
20. Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study
21. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer
22. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
23. Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer
24. The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
25. 890: Impact of cumulative cisplatin-dose on distant metastasis after chemoradiation of cervical cancer
26. Essais et nouvelles perspectives dans la radiothérapie des cancers de l’endomètre
27. Clinical outcomes after interstitial brachytherapy for early-stage nasal squamous cell carcinoma
28. Diffusion-weighted MRI in image-guided adaptive brachytherapy: Tumor delineation feasibility study and comparison with GEC-ESTRO guidelines
29. Pulsed-dose rate brachytherapy for pediatric bladder prostate rhabdomyosarcoma: Compliance and early clinical results
30. Locally advanced cervical cancer: Is it relevant to report image-guided adaptive brachytherapy using point A dose?
31. Assessment of the novel online delineation workshop dummy run approach using FALCON within a European multicentre trial in cervical cancer (RAIDs)
32. Contribution of image-guided adaptive brachytherapy to pelvic nodes treatment in locally advanced cervical cancer
33. Outcome of early stage cervical cancer patients treated according to a radiosurgical approach: Clinical results and prognostic factors
34. Genito-Urinary Tumours
35. Tumor dose–volume response in image-guided adaptive brachytherapy for cervical cancer: A meta-regression analysis
36. Post radiation hysterectomy in locally advanced cervical cancer: Outcomes and dosimetric impact
37. Preoperative image-guided brachytherapy in early stage cervical cancers
38. A volumetric analysis of GTVD and CTVHR as defined by the GEC ESTRO recommendations in FIGO stage IIB and IIIB cervical cancer patients treated with IGABT in a prospective multicentric trial (EMBRACE)
39. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer
40. Dose–volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study
41. Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study
42. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study
43. Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors
44. Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
45. Image-guided adaptive brachytherapy in cervical cancer: Patterns of relapse by brachytherapy planning parameters
46. MRI-guided brachytherapy in locally advanced cervical cancer: Small bowel [formula omitted] and [formula omitted] are not predictive of late morbidity
47. Quality of life and functional outcome of male patients with bladder–prostate rhabdomyosarcoma treated with conservative surgery and brachytherapy during childhood
48. Vaginal dose assessment in image-guided brachytherapy for cervical cancer: Can we really rely on dose-point evaluation?
49. Dose–effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study
50. Late toxicity of brachytherapy after female genital tract tumors treated during childhood: Prospective evaluation with a long-term follow-up
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.